We are live on ! Find out more
USNA icon

Usana Health Sciences

192 hedge funds and large institutions have $871M invested in Usana Health Sciences in 2020 Q3 according to their latest regulatory filings, with 25 funds opening new positions, 58 increasing their positions, 76 reducing their positions, and 24 closing their positions.

New
Increased
Maintained
Reduced
Closed

115% more call options, than puts

Call options by funds: $758K | Put options by funds: $353K

4% more first-time investments, than exits

New positions opened: 25 | Existing positions closed: 24

0% more funds holding

Funds holding: 192192 (0)

0.8% less ownership

Funds ownership: 57.33%56.54% (-0.8%)

2% less capital invested

Capital invested by funds: $884M → $871M (-$13.7M)

24% less repeat investments, than reductions

Existing positions increased: 58 | Existing positions reduced: 76

Holders
192
Holders Change
Holders Change %
0%
% of All Funds
3.87%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
25
Increased
58
Reduced
76
Closed
24
Calls
$758K
Puts
$353K
Net Calls
+$405K
Net Calls Change
+$1.37M

USNA Hedge Fund Activity: Q3 2020 in Review

192 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in Usana Health Sciences (USNA) for Q3 2020, worth a combined $871M — down 1.6% from $884M a quarter earlier.

Buyers outnumbered sellers: 25 funds opened new USNA positions and 24 closed out — a net gain of 1 holder — while 58 added to existing stakes and 76 trimmed.

The largest buyer was CAAS Capital Management, opening a new position worth an estimated $14.8M. The largest seller was Millennium Management, cutting an estimated $9.37M.

  • 192 institutional investors held Usana Health Sciences (USNA) as of Q3 2020, unchanged from Q2 2020.
  • Funds reported $871M of Usana Health Sciences stock for Q3 2020, down 1.6% quarter-over-quarter.
  • 25 funds opened new Usana Health Sciences positions in Q3 2020 and 24 closed out, a net change of +1 holder.
  • The largest Usana Health Sciences buyer in Q3 2020 was CAAS Capital Management, an estimated $14.8M added.
  • The largest Usana Health Sciences seller in Q3 2020 was Millennium Management, an estimated $9.37M sold.

Based on aggregated 13F filings for Q3 2020.